Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.

Although stem-cell therapies have been suggested for cardiac-regeneration after myocardial-infarction (MI), key-questions regarding the in-vivo cell-fate remain unknown. While most available animal-models require immunosuppressive-therapy when applying human cells, the fetal-sheep being pre-immune u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maximilian Y Emmert, Benedikt Weber, Petra Wolint, Thomas Frauenfelder, Steffen M Zeisberger, Luc Behr, Sebastien Sammut, Jacques Scherman, Chad E Brokopp, Ruth Schwartländer, Viola Vogel, Peter Vogt, Jürg Grünenfelder, Hatem Alkadhi, Volkmar Falk, Andreas Boss, Simon P Hoerstrup
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5fba4efe39af4c2b8a27005f84126fbb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5fba4efe39af4c2b8a27005f84126fbb
record_format dspace
spelling oai:doaj.org-article:5fba4efe39af4c2b8a27005f84126fbb2021-11-18T07:52:22ZIntramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.1932-620310.1371/journal.pone.0057759https://doaj.org/article/5fba4efe39af4c2b8a27005f84126fbb2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23533575/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Although stem-cell therapies have been suggested for cardiac-regeneration after myocardial-infarction (MI), key-questions regarding the in-vivo cell-fate remain unknown. While most available animal-models require immunosuppressive-therapy when applying human cells, the fetal-sheep being pre-immune until day 75 of gestation has been proposed for the in-vivo tracking of human cells after intra-peritoneal transplantation. We introduce a novel intra-uterine myocardial-infarction model to track human mesenchymal stem cells after direct intra-myocardial transplantation into the pre-immune fetal-sheep. Thirteen fetal-sheep (gestation age: 70-75 days) were included. Ten animals either received an intra-uterine induction of MI only (n = 4) or MI+intra-myocardial injection (IMI;n = 6) using micron-sized, iron-oxide (MPIO) labeled human mesenchymal stem cells either derived from the adipose-tissue (ATMSCs;n = 3) or the bone-marrow (BMMSCs;n = 3). Three animals received an intra-peritoneal injection (IPI;n = 3; ATMSCs;n = 2/BMMSCs;n = 1). All procedures were performed successfully and follow-up was 7-9 days. To assess human cell-fate, multimodal cell-tracking was performed via MRI and/or Micro-CT, Flow-Cytometry, PCR and immunohistochemistry. After IMI, MRI displayed an estimated amount of 1×10(5)-5×10(5) human cells within ventricular-wall corresponding to the injection-sites which was further confirmed on Micro-CT. PCR and IHC verified intra-myocardial presence via detection of human-specific β-2-microglobulin, MHC-1, ALU-Sequence and anti-FITC targeting the fluorochrome-labeled part of the MPIOs. The cells appeared viable, integrated and were found in clusters or in the interstitial-spaces. Flow-Cytometry confirmed intra-myocardial presence, and showed further distribution within the spleen, lungs, kidneys and brain. Following IPI, MRI indicated the cells within the intra-peritoneal-cavity involving the liver and kidneys. Flow-Cytometry detected the cells within spleen, lungs, kidneys, thymus, bone-marrow and intra-peritoneal lavage, but not within the heart. For the first time we demonstrate the feasibility of intra-uterine, intra-myocardial stem-cell transplantation into the pre-immune fetal-sheep after MI. Utilizing cell-tracking strategies comprising advanced imaging-technologies and in-vitro tracking-tools, this novel model may serve as a unique platform to assess human cell-fate after intra-myocardial transplantation without the necessity of immunosuppressive-therapy.Maximilian Y EmmertBenedikt WeberPetra WolintThomas FrauenfelderSteffen M ZeisbergerLuc BehrSebastien SammutJacques SchermanChad E BrokoppRuth SchwartländerViola VogelPeter VogtJürg GrünenfelderHatem AlkadhiVolkmar FalkAndreas BossSimon P HoerstrupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e57759 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maximilian Y Emmert
Benedikt Weber
Petra Wolint
Thomas Frauenfelder
Steffen M Zeisberger
Luc Behr
Sebastien Sammut
Jacques Scherman
Chad E Brokopp
Ruth Schwartländer
Viola Vogel
Peter Vogt
Jürg Grünenfelder
Hatem Alkadhi
Volkmar Falk
Andreas Boss
Simon P Hoerstrup
Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
description Although stem-cell therapies have been suggested for cardiac-regeneration after myocardial-infarction (MI), key-questions regarding the in-vivo cell-fate remain unknown. While most available animal-models require immunosuppressive-therapy when applying human cells, the fetal-sheep being pre-immune until day 75 of gestation has been proposed for the in-vivo tracking of human cells after intra-peritoneal transplantation. We introduce a novel intra-uterine myocardial-infarction model to track human mesenchymal stem cells after direct intra-myocardial transplantation into the pre-immune fetal-sheep. Thirteen fetal-sheep (gestation age: 70-75 days) were included. Ten animals either received an intra-uterine induction of MI only (n = 4) or MI+intra-myocardial injection (IMI;n = 6) using micron-sized, iron-oxide (MPIO) labeled human mesenchymal stem cells either derived from the adipose-tissue (ATMSCs;n = 3) or the bone-marrow (BMMSCs;n = 3). Three animals received an intra-peritoneal injection (IPI;n = 3; ATMSCs;n = 2/BMMSCs;n = 1). All procedures were performed successfully and follow-up was 7-9 days. To assess human cell-fate, multimodal cell-tracking was performed via MRI and/or Micro-CT, Flow-Cytometry, PCR and immunohistochemistry. After IMI, MRI displayed an estimated amount of 1×10(5)-5×10(5) human cells within ventricular-wall corresponding to the injection-sites which was further confirmed on Micro-CT. PCR and IHC verified intra-myocardial presence via detection of human-specific β-2-microglobulin, MHC-1, ALU-Sequence and anti-FITC targeting the fluorochrome-labeled part of the MPIOs. The cells appeared viable, integrated and were found in clusters or in the interstitial-spaces. Flow-Cytometry confirmed intra-myocardial presence, and showed further distribution within the spleen, lungs, kidneys and brain. Following IPI, MRI indicated the cells within the intra-peritoneal-cavity involving the liver and kidneys. Flow-Cytometry detected the cells within spleen, lungs, kidneys, thymus, bone-marrow and intra-peritoneal lavage, but not within the heart. For the first time we demonstrate the feasibility of intra-uterine, intra-myocardial stem-cell transplantation into the pre-immune fetal-sheep after MI. Utilizing cell-tracking strategies comprising advanced imaging-technologies and in-vitro tracking-tools, this novel model may serve as a unique platform to assess human cell-fate after intra-myocardial transplantation without the necessity of immunosuppressive-therapy.
format article
author Maximilian Y Emmert
Benedikt Weber
Petra Wolint
Thomas Frauenfelder
Steffen M Zeisberger
Luc Behr
Sebastien Sammut
Jacques Scherman
Chad E Brokopp
Ruth Schwartländer
Viola Vogel
Peter Vogt
Jürg Grünenfelder
Hatem Alkadhi
Volkmar Falk
Andreas Boss
Simon P Hoerstrup
author_facet Maximilian Y Emmert
Benedikt Weber
Petra Wolint
Thomas Frauenfelder
Steffen M Zeisberger
Luc Behr
Sebastien Sammut
Jacques Scherman
Chad E Brokopp
Ruth Schwartländer
Viola Vogel
Peter Vogt
Jürg Grünenfelder
Hatem Alkadhi
Volkmar Falk
Andreas Boss
Simon P Hoerstrup
author_sort Maximilian Y Emmert
title Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
title_short Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
title_full Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
title_fullStr Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
title_full_unstemmed Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
title_sort intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/5fba4efe39af4c2b8a27005f84126fbb
work_keys_str_mv AT maximilianyemmert intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT benediktweber intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT petrawolint intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT thomasfrauenfelder intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT steffenmzeisberger intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT lucbehr intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT sebastiensammut intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT jacquesscherman intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT chadebrokopp intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT ruthschwartlander intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT violavogel intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT petervogt intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT jurggrunenfelder intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT hatemalkadhi intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT volkmarfalk intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT andreasboss intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
AT simonphoerstrup intramyocardialtransplantationandtrackingofhumanmesenchymalstemcellsinanovelintrauterinepreimmunefetalsheepmyocardialinfarctionmodelaproofofconceptstudy
_version_ 1718422853958762496